Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03103061 · ClinicalTrials.gov registry record · Phase 2
Use of Lexiscan for Myocardial Stress Perfusion Computed Tomography With a 3rd Generation Dual Source CT System
A Phase 2 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
NCT03103061 is a Phase 2 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 24 participants.
The verdict
NCT03103061, a Phase 2 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the feasibility, tolerability, safety, and image quality of low-radiation, dynamic perfusion CT of the heart in patients with suspected ischemic chest pain and a moderate or severe stenosis seen on coronary CTA. Secondary aims include the assessment of the diagnostic accuracy of CT perfusion imaging compared to either SPECT or invasive angiography.
Interventions
- DRUG Lexiscan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2016-02-09 |
| Est. Completion | 2018-06-14 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03103061
The ClinicalTrials.gov registry entry for NCT03103061 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lexiscan is the first listed.
NCT03103061 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03103061 about?
NCT03103061 is a clinical study titled "Use of Lexiscan for Myocardial Stress Perfusion Computed Tomography With a 3rd Generation Dual Source CT System". The purpose of this study is to evaluate the feasibility, tolerability, safety, and image quality of low-radiation, dynamic perfusion CT of the heart in patients with suspected ischemic chest pain and a moderate or severe stenosis seen on coronary CTA. Secondary aims include the assessment of the di...
What is the current status of trial NCT03103061?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2016-02-09. Estimated completion is 2018-06-14.
What interventions are being tested in trial NCT03103061?
The interventions under investigation include: Lexiscan (DRUG).
Who is sponsoring clinical trial NCT03103061?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.